SCHEMBL12020146

SCHEMBL12020146

O=NC(=O)[C@@H]1CCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6689415 1.00
SCHEMBL15457829 1.00
SCHEMBL8341890 0.93 DPP4 (0.40)
SCHEMBL14161302 0.88
SCHEMBL16015160 0.80
SCHEMBL20781411 0.80
SCHEMBL1466543 0.80
SCHEMBL4687046 0.78 DPP4 (0.42)
SCHEMBL30978361 0.77 DPP4 (0.45)
SCHEMBL15360284 0.77 NOS2 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3003385-B1 ANTIBODY COMPOSITION AND BUFFER SYSTEM THEREFOR INNOVA BIOSCIENCES LTD (GB) 2019-09-18 EP disclosed
US-9644005-B2 Didemnin biosynthetic gene cluster in Tistrella mobilis KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2017-05-09 US disclosed
EP-2758519-B1 DIDEMNIN BIOSYNTHETIC GENE CLUSTER IN TISTRELLA MOBILIS UNIV KING ABDULLAH SCI & TECH (SA) 2017-03-29 EP disclosed
EP-3020723-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS Enanta Pharmaceuticals, Inc. (US) 2016-05-18 EP disclosed
WO-2015191705-A1 NON-CANONICAL INSULINS AND THEIR USES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2015-12-17 WO disclosed
US-20140296161-A1 DIDEMNIN BIOSYNTHETIC GENE CLUSTER IN TISTRELLA MOBILIS KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) 2014-10-02 US disclosed
WO-2013163466-A1 INHIBITORS OF HEPATITIS C VIRUS PRESIDIO PHARMACEUTICALS, INC. (US) 2013-10-31 WO disclosed
EP-2491933-A1 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION Astellas Pharma Inc. (JP) 2012-08-29 EP disclosed